Login here to update your profile  
My Profile

Kendra Vehik, MPH, PhD




profile Image
Email: kvehik@health.usf.edu
Office: MDC, 113
Mailing address 3650 Spectrum Blvd. STE 100
Tampa, FL 33612
  • PhD, Analytic Health Sciences, University Of Colorado, United States - 2007.
  • Ph.D., Epidemiology, University of Colorado, USA - 2007.
  • M.P.H., Epidemiology and Biostatistics, George Washington University, USA - 1996.
  • B.S., Biology, University of Arizona, USA - 1993.
Research Summary

Dr. Kendra Vehik is an Assistant Professor at the University of South Florida. Her research interests are focused on type 1 diabetes including prevention, clinical/translational and quality of life research. Much of her published work has been focused on identifying probable risk factors associated with type 1 diabetes in order to develop more directed hypotheses to prevent the onset of autoimmunity and clinical disease. She has expertise in epidemiologic and biostatistical methodologies associated with case/control, longitudinal and clinical trial designs. Dr. Vehik has firsthand knowledge and experience working with many type 1 clinical projects coordinated by the Pediatric Epidemiology Center, including The Environmental Determinants of Diabetes in the Young (TEDDY), TrialNet Network and the Diabetes Prevention Trial – Type 1 (DPT-1) studies. Her main diabetes expertise lies in identifying stable and informative risk factors and validating the identified risk factors as triggers and/or accelerators of autoimmunity and clinical disease. She has authored many high impact peer-reviewed publications that have focused on determining risk factors associated with type 1 diabetes focused on in utero and early life environmental exposures (body size and growth patterns, nutrition, infections), genetic susceptibility, clinical outcomes in delaying onset and population-based temporal trends in risk factors and type 1 diabetes. Her long time interests are in identifying early life risk factors, exploring how changes in these risk factors over time and potential gene-environment interactions contribute to the risk of autoantibody seroconversion and surrogate biomarkers for prediction, diagnosis and risk of type 1 diabetes, and delaying or stopping the onset of diabetes.


Selected Publications

  • "Islet antibody remission and risk of type 1 diabetes in very young patients in the TEDDY Study" Immunology of Diabetes Society . Australia - 2013.
  • "Early infant feeding and islet autoimmunity in The Environmental Determinants of Diabetes in the You" Immunology of Diabetes Society (co-presenter). Australia - 2013.
  • "The six-year incidence of diabetes associated autoantibodies in the genetically at-risk: The TEDDY S" Immunology of Diabetes Society (co-presenter). Australia - 2013.
  • "Increased weight or height gain in infants or toddlers does not predict early development of T1D: Th" Immunology of Diabetes Society (co-presenter). Australia - 2013.
  • "Prevalence of obesity in young children genetically at-risk for type 1 diabetes (co-presenter)" American Diabetes Association. PA, United States - 2012.
  • "Rising hemoglobin A1c in the non-diabetic range accelerates time to development of type 1 diabetes i" European Diabetes Epidemiology Group Meeting (co-presenter). United Kingdom - 2012.
  • "Requirements and strategy for the development of a pediatric drug ontology (co-presenter)" Int’l Conference on Formal Ontology in Information Systems. Austria - 2012.

Profile last modified on 01/06/2015